Erectile dysfunction: Why drug therapy isn't always enough
Stephen B. Levine, MD
Clinical Professor of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH; Co-Director, Center for Marital and Sexual Health, and President, Center for Sexual Health Research, Beachwood, OH
Address: Stephen B. Levine, MD, Center for Marital and Sexual Health, 3 Commerce Park Square, Suite 350, Beachwood, OH 44122-5402
The author has indicated that he has received grant or research support from Pfizer corporation, is a consultant for Lilly-ICOS, and is on the speakers' bureaus of the Consortium for Improvement in Erectile Function and Pfizer.
The presentation on which this article is based was supported by an unrestricted educational grant from Lilly-ICOS LLC.
This article discusses therapies that are not approved by the US Food and Drug Administration.
Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.
ABSTRACTWe increasingly recognize that erectile dysfunction (ED) usually arises from a mix of organic and psychogenic causes, yet management of this condition too often neglects the complexity of most cases of ED. While therapy with sildenafil and similar investigational drugs can play an important role in many cases of ED, physicians should recognize and try to address the psychological and interpersonal context in which ED exists in their patients.